Picture News

    Past(2000-2019) and Future(2020-2024) Trends of Brain Cancer Mortality in China
  • Data from our National Cancer Center showed that there were 16,351 deaths from brain tumors in 2016, ranking 10th in the spectrum of cancer deaths in China. The top 3 countries with the highest number of brain tumor deaths worldwide in 2020 were China, India, and the United States. Once a brain tumor occurs, it can lead to increased intracranial pressure and compression of brain tissue, resulting in painful and severe central nervous system damage, as well as serious disabilities, including seizures, memory or speech problems, and physical dysfunction. The disease burden of brain tumors in China is also increasing year by year due to their special location, complex diagnostic tools, and the gradual aging of population, and they have become a difficult issue in the prevention and treatment of chronic diseases in China. Therefore, conducting studies on the long-term epidemiological characteristics of brain tumors in China and predicting future changes appropriately can help to obtain clues on the etiology of brain tumors and provide timely scientific and effective means of prevention and control.

    This study extracted data related to brain tumor deaths in China from the Global Burden of Disease Study 2019 (GBD 2019) from 2000-2019, and used Joinpoint regression model, age-time cohort (APC) model to analyze and evaluate the mortality rate, and predicted the mortality trend of brain tumor in the next 5 years by using gray model GM (1, 1), aiming to provide a basis for the prevention and control of brain tumor and reduce the disease burden in China.

    Data of brain cancer deaths in China from 2000 to 2019 were extracted from the Global Burden of Disease Study 2019including CMR and agestandardized mortality rateASMRcalculated using the age composition of the 2019 world population. The mortality trend was analyzed by Joinpoint regression model. The ageperiod and birth cohort effects of CMR were estimated by intrinsic estimator IEand age-period-cohort model APC model. GM11model was established by R4.1.3to predict the CMR of brain cancers in 2020-2024. 

    The Joinpoint regression analysis the ASMR of brain cancers showed a downward trend in the whole population,male and female populations. The ASMR of brain cancers in the whole population,male and female populations decreased by 0.68%,0.47%,and 0.87% on average each year,respectively from 2000 to 2019(P<0.05). The APC analysis revealed that the death risk of brain cancers in both Chinese male and female populations increased with age and period. The death risk of brain cancers in the late birth cohort was lower than that in the early birth cohort,that is,the effect coefficient decreased from 0.62 in the 1904-1908 birth cohort to -1.28 in the 2014-2019 birth cohort in male,and that increased from 0.36 in the 1904-1908 female cohort to 0.57 in the 1929-1933 birth cohort,then it gradually decreased,and hit its lowest point in the 2014-2019 birth cohort (-1.16) in female. GM(1,1) model predicted that the CMR of brain cancers in China would continue to rise after 2019,reaching 4.34/105 in 2020,4.39/105 in 2021,4.44/105 in 2022,4.49/105 in 2023 and 4.54/105 in 2024. 

    In summary, the overall trend of brain tumor ASMR in China from 2000 to 2019 is decreasing, and the risk of death increases with age and period passage, and the earlier of birth, the greater risk of death will be. The model prediction results show that the mortality rate of brain tumors in China will continue to rise in the next 5 years, and the situation of brain tumor prevention and control in China remains severe. The increasingly prominent problem of population aging in China may also further aggravate the disease burden of brain tumors in the future. Therefore, the prevention and treatment of brain tumors in China should focus on the elderly population, while reducing occupational exposure, quitting smoking, limiting alcohol, maintaining body mass in the appropriate range, and strengthening the publicity and education of brain tumor prevention. We should further strengthen the early diagnosis and treatment of brain tumors in the middle-aged and elderly population with a high incidence of brain tumors aged over 50 years[34], and find treatments that are more effective in treating brain tumors to reduce the disease burden. Strengthening the collection and collation of tumor registry data of brain tumors in China, especially the comprehensive understanding of different pathological types of brain tumors, is of great significance to further reduce the disease burden of brain tumors in China.




  • Pubdate: 2023-07-06    Viewed: 270